로딩 중…
지수 로딩 중…
MEDIPOST Co., Ltd.
078160· KOSDAQ· Health Care· Health Care Equipment & Services
₩9,520-6.21%
2026-06-19
Price Chart
MEDIPOST Co., Ltd.-19.39%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 373.23B KRW |
| Revenue | 73.90B KRW |
| Net Income | -79.73B KRW |
| Total Assets | 577.70B KRW |
| Net Assets | 241.25B KRW |
| Employees | 648 |
| Value | |
| P/B | 1.55x |
| P/S | 5.05x |
| FCF Yield | -16.09% |
| Profitability | |
| ROE | -33.05% |
| ROA | -13.80% |
| Op. Margin | -96.31% |
| Revenue Growth | 1.24% |
| Financial Health | |
| Debt Ratio | 239.46% |
| Total Debt | 162.97B KRW |
| FCF | -60.06B KRW |
| Cash | 102.54B KRW |
| Current Ratio | 1.08x |
| Performance | |
| 1Y Return | -19.39% |
| 1M Return | -31.95% |
| From 52W High | -67.29% |
| 1Y MDD | -66.46% |
| Trading | |
| Volume | 147,595 shares |
| Foreign Own. | 3.59% |
| Per Share | |
| EPS | -2,061 KRW |
| BPS | 6,153 KRW |
Company Info
Medipost, established in 2000 and listed on KOSDAQ in 2005, specializes in umbilical cord blood banking and stem cell therapy development. The company operates an umbilical cord blood bank, sells the degenerative arthritis treatment Cartistem, and develops umbilical cord blood-derived stem cell therapies. It also engages in the health functional food business, offering multivitamins and probiotics. Medipost is headquartered in Seongnam-si, Gyeonggi-do, and actively expands its market reach through awareness campaigns, global clinical trials for Cartistem, and diversified online marketing channels.